InMode (INMD) EBITDA Margin (2018 - 2026)
InMode (INMD) posted EBITDA Margin of 13.01% for the quarter ended Jun 30, 2026, down 11.12 percentage points from 24.13% a year earlier but up 0.54 percentage points from the prior quarter.
InMode (INMD) EBITDA Margin (2018 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA Margin at InMode was 18.65%, down 10.08 percentage points year-over-year; for the year ended Dec 31, 2025, it came in at 23.23%, down 5.45 percentage points from the prior year.
- Annual EBITDA Margin has declined for four consecutive years, with a five-year change of -12.31 percentage points (years ended Dec 2020 to Dec 2025).
- In prior years, InMode's EBITDA Margin was 28.69% in the year ended Dec 31, 2024 (-11.20 pp), 39.89% in the year ended Dec 31, 2023 (-3.81 pp), 43.70% in the year ended Dec 31, 2022 (-3.28 pp) and 46.98% in the year ended Dec 31, 2021 (+11.44 pp).
- Quarterly EBITDA Margin has run from a low of 12.47% in the quarter ended Mar 31, 2026 to a high of 49.11% in the quarter ended Dec 31, 2021 over five years.
- On a year-over-year basis, EBITDA Margin has declined in each of the last four quarters, with an average year-over-year change of -6.15 percentage points over the last eight quarters.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was the quarter ended Sep 30, 2021, with a gain of 8.76 percentage points; the weakest was the quarter ended Jun 30, 2024, with a drop of 20.64 percentage points.
- According to Business Quant data, EBITDA Margin for the three prior quarters was 12.47% (quarter ended Mar 31, 2026), 25.19% (quarter ended Dec 31, 2025) and 22.60% (quarter ended Sep 30, 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 251.30 Bn | 230.45 Bn | 4.88 Bn | 24.20% |
| 2 | Abbott Laboratories | 174.70 Bn | 145.78 Bn | 7.27 Bn | 21.86% |
| 3 | Danaher | 158.94 Bn | 142.76 Bn | 3.61 Bn | 28.51% |
| 4 | Intuitive Surgical | 145.87 Bn | 125.42 Bn | 1.96 Bn | 41.08% |
| 5 | Medtronic | 111.49 Bn | 77.36 Bn | 6.34 Bn | 25.55% |
| 6 | Stryker | 106.96 Bn | 93.08 Bn | 4.50 Bn | 29.67% |
| 7 | Boston Scientific | 63.62 Bn | 58.63 Bn | 3.85 Bn | 28.17% |
| 8 | Edwards Lifesciences | 50.80 Bn | 34.92 Bn | 1.35 Bn | 31.93% |
| 9 | Becton Dickinson | 49.59 Bn | 46.74 Bn | 2.32 Bn | 24.62% |
| 10 | InMode | 900.96 Mn | -725.66 Mn | 71.52 Mn | 13.01% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.01% |
| Mar 31, 2026 | 12.47% |
| Dec 31, 2025 | 25.19% |
| Sep 30, 2025 | 22.60% |
| Jun 30, 2025 | 24.13% |
| Mar 31, 2025 | 20.28% |
| Dec 31, 2024 | 28.73% |
| Sep 30, 2024 | 37.16% |
| Jun 30, 2024 | 21.39% |
| Mar 31, 2024 | 22.74% |
| Dec 31, 2023 | 40.52% |
| Sep 30, 2023 | 37.80% |
| Jun 30, 2023 | 42.03% |
| Mar 31, 2023 | 38.83% |
| Dec 31, 2022 | 45.01% |
| Sep 30, 2022 | 44.47% |
| Jun 30, 2022 | 43.47% |
| Mar 31, 2022 | 40.91% |
| Dec 31, 2021 | 49.11% |
| Sep 30, 2021 | 47.95% |
InMode EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=INMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "INMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=INMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();